Toxicology in Vitro 2012-06-01

Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro.

Jie Li, Donglan Zhang, Kathleen M Ward, George C Prendergast, Iraimoudi S Ayene

Index: Toxicol. In Vitro 26(4) , 603-12, (2012)

Full Text: HTML

Abstract

Cell viability assays have a variety of well known practical and technical limitations. All the available approaches have disadvantages, such as non-linearity, high background and cumbersome protocols. Several commonly used tetrazolium chemicals rely upon generation of a colored formazan product formed by mitochondrial reduction of these compounds via phenazine methosulfate (PMS). However, sensitivity is inherently limited because their reduction relies on mitochondrial bioreduction and cellular transport of PMS, as well as accessibility to tetrazolium chemicals. In this study, we identify hydroxethyldisulfide (HEDS) as an inexpensive probe that can measure cellular metabolic activity without the need of PMS. In tissue culture medium, HEDS accurately quantitated metabolically active live cells in a linear manner superior to tetrazolium based and other assays. Cell toxicity produced by chemotherapeutics (cisplatin, etoposide), oxidants (hydrogen peroxide, acetaminophen), toxins (phenyl arsine oxide, arsenite) or ionizing radiation was rapidly determined by the HEDS assay. We found that HEDS was superior to other commonly used assays for cell viability determinations in its solubility, membrane permeability, and intracellular conversion to a metabolic reporter that is readily transported into the extracellular medium. Our findings establish the use of HEDS in a simple, rapid and low cost assay to accurately quantify viable cells.Copyright © 2012 Elsevier Ltd. All rights reserved.


Related Compounds

  • Arsine, oxophenyl-
  • 2,2'-DITHIODIE...

Related Articles:

Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties.

2015-01-01

[Int. J. Nanomedicine 10 , 5355-66, (2015)]

Piperine inhibits the growth and motility of triple-negative breast cancer cells.

2015-02-01

[Cancer Lett. 357(1) , 129-40, (2014)]

Differential regulation of GLUT1 activity in human corneal limbal epithelial cells and fibroblasts.

2013-02-01

[Biochimie 95(2) , 258-63, (2013)]

TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant.

2014-01-01

[J. Transl. Med. 12 , 211, (2014)]

Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain.

2015-10-12

[Eur. J. Pharm. Sci. 78 , 19-30, (2015)]

More Articles...